ArticleFrontiers in immunology2026

Zapnometinib treatment and influenza A virus infection modulate the HLA class I ligandome in human lung adenocarcinoma cells.

Hazem Hamza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.